Because FOXM1 promotes the gene expression of its targets, we also utilized RT-qPCR to measure the expression of four well characterized FOXM1 mRNA targets following NB compound treatment (FOXM1, CCNB1, SKP2, CDC25B). The gene discussed is CCNB1; the disease is neuroblastoma.